Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.140
+0.230 (12.04%)
At close: Mar 9, 2026, 4:00 PM EDT
2.200
+0.060 (2.82%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Ovid Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 279 | 66 | 228 | 131 | 219 | 147 | |
| Market Cap Growth | 591.30% | -70.87% | 73.64% | -40.03% | 49.16% | -26.16% | |
| Enterprise Value | 267 | 19 | 157 | 9 | 17 | 60 | |
| Last Close Price | 2.14 | 0.93 | 3.22 | 1.86 | 3.21 | 2.31 | |
| PE Ratio | - | - | - | - | 1.82 | - | |
| PS Ratio | 42.15 | 117.14 | 580.59 | 87.22 | 1.05 | 11.61 | |
| PB Ratio | 3.41 | 0.97 | 2.59 | 0.99 | 1.22 | 3.36 | |
| P/TBV Ratio | 6.23 | 0.97 | 2.60 | 0.99 | 1.22 | 3.38 | |
| P/FCF Ratio | - | - | - | - | 1.85 | - | |
| P/OCF Ratio | - | - | - | - | 1.84 | - | |
| EV/Sales Ratio | 40.36 | 32.98 | 400.05 | 6.30 | 0.08 | 4.73 | |
| EV/EBITDA Ratio | - | - | - | - | 0.14 | - | |
| EV/EBIT Ratio | - | - | - | - | 0.14 | - | |
| EV/FCF Ratio | - | - | - | - | 0.14 | - | |
| Debt / Equity Ratio | 0.31 | 0.22 | 0.18 | 0.13 | - | - | |
| Net Debt / Equity Ratio | -0.26 | -0.56 | -1.02 | -0.85 | -1.04 | -1.65 | |
| Net Debt / EBITDA Ratio | 0.31 | 0.66 | 1.58 | 2.04 | -1.51 | 0.89 | |
| Net Debt / FCF Ratio | 0.31 | 0.68 | 1.96 | 1.99 | -1.59 | 1.39 | |
| Asset Turnover | 0.08 | 0.01 | 0.00 | 0.01 | 1.54 | 0.16 | |
| Quick Ratio | 3.77 | 5.04 | 9.23 | 18.45 | 12.69 | 3.27 | |
| Current Ratio | 4.24 | 5.32 | 9.55 | 18.79 | 12.87 | 3.39 | |
| Return on Equity (ROE) | -60.06% | -33.88% | -47.57% | -34.72% | 109.98% | -142.60% | |
| Return on Assets (ROA) | -29.33% | -30.90% | -24.05% | -19.85% | 57.40% | -64.93% | |
| Return on Invested Capital (ROIC) | -121.33% | -418.97% | -648.00% | -392.69% | - | - | |
| Return on Capital Employed (ROCE) | -68.50% | -71.50% | -43.40% | -37.50% | 69.10% | -151.20% | |
| Earnings Yield | -12.88% | -39.87% | -23.00% | -41.33% | 56.20% | -55.30% | |
| FCF Yield | -13.62% | -84.50% | -20.13% | -43.07% | 54.18% | -35.29% | |
| Buyback Yield / Dilution | -0.35% | -0.46% | -0.22% | -3.46% | -16.45% | -49.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.